Literature DB >> 7627895

Prostacyclin-thromboxane balance and retinal vascular pattern in rats with experimentally induced diabetes.

A Moreno1, J P De La Cruz, J Garcia Campos, F Sanchez De La Cuesta.   

Abstract

OBJECTIVE: To search for relationships between alterations in vascular and platelet function and the retinal vascular pattern in male Wistar rats with streptozocin-induced diabetes after various periods of evolution of the disease. NUMBERS: Five groups of five diabetic rats were studied, the duration of diabetes being 15 days or 2, 3, 6 or 9 months; a control group comprised six nondiabetic rats. Each diabetic rat that died was replaced with a new animal, for a total of 46 animals. All deaths occurred within the first 5 days of induction of the disease. MAIN OUTCOME MEASURES: Blood glucose level, intensity of platelet aggregation, thromboxane B2 level, aortic 6-keto-prostaglandin F1 alpha level, retinal vascular morphology, percentage of retinal area covered by vessels stained with horseradish peroxidase (HRP) in photomicrographs.
RESULTS: Thromboxane B2 production increased with the duration of diabetes (r = 0.91, p < 0.001), and aortic 6-keto-PGF1 alpha production decreased in relation to blood glucose concentration (r = -0.95, p < 0.003). Alterations in retinal vascular pattern were related to both blood glucose and vascular prostacyclin concentrations. The retinal area covered by HRP-stained vessels was 79.3% lower in the diabetic rats than in the nondiabetic rats, and this inhibition was maintained throughout the experimental period.
CONCLUSIONS: We postulate that a decrease in prostacyclin production in association with high glucose levels plays an important role in the development of retinal vascular alterations in streptozocin-diabetic rats, although an influence of thromboxane cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627895

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  5 in total

1.  Attenuation of streptozotocin-induced microvascular changes in the mouse retina with the endothelin receptor A antagonist atrasentan.

Authors:  Zhongli Wang; Amit Singh Yadav; Wendy Leskova; Norman R Harris
Journal:  Exp Eye Res       Date:  2010-08-19       Impact factor: 3.467

2.  Hypoxia and the expression of HIF-1alpha and HIF-2alpha in the retina of streptozotocin-injected mice and rats.

Authors:  William S Wright; Robert M McElhatten; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2009-12-11       Impact factor: 3.467

3.  Attenuation of diabetes-induced retinal vasoconstriction by a thromboxane receptor antagonist.

Authors:  William S Wright; Jodine E Messina; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-11-01       Impact factor: 3.467

4.  Ozagrel attenuates early streptozotocin-induced constriction of arterioles in the mouse retina.

Authors:  William S Wright; Norman R Harris
Journal:  Exp Eye Res       Date:  2008-01-09       Impact factor: 3.467

5.  Expression of thromboxane synthase and the thromboxane-prostanoid receptor in the mouse and rat retina.

Authors:  William S Wright; Robert M McElhatten; Norman R Harris
Journal:  Exp Eye Res       Date:  2009-06-11       Impact factor: 3.467

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.